Keyphrases
Glioma Model
100%
Oncolytic HSV
100%
Tumor
33%
Herpes Simplex Virus Type 1 (HSV-1)
33%
Brain Tumor
33%
HSV-1 Infection
22%
Immunogenic
22%
Murine Model
22%
HSV1716
22%
Virus
22%
Immune-competent
22%
Biotherapy
22%
Microglia
11%
Efficacy Testing
11%
Tumor Genetics
11%
G207
11%
Host Interaction
11%
Japan
11%
Tumor Cells
11%
Viral Therapy
11%
Poor Prognosis
11%
Tumor Growth
11%
Safety Testing
11%
Biological Therapy
11%
Transgenic Mice
11%
Genetic Modification
11%
GBM Model
11%
Human Brain Tumor
11%
Chemotherapy
11%
Virus Binding
11%
Solid Tumors
11%
Radiotherapy
11%
Patient Survival
11%
Primary Brain Tumor
11%
Virus Entry
11%
Mouse Model
11%
Endothelial Cells
11%
Nectin-1
11%
Immune Environment
11%
Recurrent GBM
11%
Tumor Treating Fields
11%
Transplantation
11%
Metastatic Melanoma
11%
Syngeneic
11%
Alternative Therapy
11%
Conditional Approval
11%
Europe
11%
Brain Cancer Cells
11%
Medicine and Dentistry
Brain Tumor
100%
Glioblastoma
100%
Neoplasm
50%
Biological Therapy
50%
HSV 1716
33%
Infection
33%
Tumor Cell
33%
Transgenic Mouse
16%
Metastatic Melanoma
16%
Tumor Progression
16%
Endothelial Cell
16%
Gene Mutation
16%
Virus Entry
16%
Oncolytic Virotherapy
16%
Solid Malignant Neoplasm
16%
Microglia
16%
G 207
16%
Radiation Therapy
16%
Nectin 1
16%
Tumor Treating Fields
16%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Brain Tumor
100%
Neoplasm
83%
HSV 1716
33%
Mouse
33%
Infection
33%
Virotherapy
16%
Chemotherapy
16%
Mouse Model
16%
Transgenic Mouse
16%
Solid Malignant Neoplasm
16%
Metastatic Melanoma
16%
Nectin 1
16%
G 207
16%
Tumor Growth
16%